The authors examined the involvement of platelet activating factor (PAF) in mediating leukocyte adherence to brain postcapillary pial venules and altering blood-brain barrier (BBB) permeability during basal conditions and during reoxy genation after asphyxia in newborn piglets, Intravital epifluo rescence videomicroscopy, closed cranial windows, and label ing of leukocytes with rhodamine 6G allowed us to obtain serial measurements of adherent leukocytes within postcapil lary venules, Blood-brain barrier breakdown was determined by optical measures of cortical extravascular fluorescence in tensity after intravenous sodium fluorescein. Superfusion of PAF over the cortex induced a dose-dependent increase in leu kocyte adherence to cerebral venules and leakage of fluores cein; with I fLmollL PAF, the magnitude of adherence and In brain and other organs, the endothelium is a major target of postischemic reperfusion injury, manifested as alterations in vascular reactivity, increases in vascular permeability, and vasogenic edema (Granger et aI. , 1989; Dirnagl, 1993) . Studies of cardiac and skeletal muscle ischemia provided the first compelling evidence that ischemia-induced microvascular injury is caused, in part, by leukocytes that become adherent to microvascular en dothelium (Engler et aI. , 1987; Jerome et aI. , 1994). Similar studies supported the concept that leukocytes are also important contributors to reperfusion injury in brain (Dirnagl, 1993; del Zoppo, 1994; Hartl et aI. , 1996). The strongest evidence is provided by reports documenting reductions in leukocyte adherence and accumulation dur ing postischemic reperfusion concomitant with signifi cant attenuation of ischemic brain injury after adminis tration of monoclonal antibodies to leukocyte or endoReceived April 14, 1998; final revision received July 16, 1998; ac cepted July 22, 1998. Abbreviations used: BBB, blood�brain barrier; PAF, platelet activating factor; SOD, superoxide dismutase.
In brain and other organs, the endothelium is a major target of postischemic reperfusion injury, manifested as alterations in vascular reactivity, increases in vascular permeability, and vasogenic edema (Granger et aI. , 1989; Dirnagl, 1993) . Studies of cardiac and skeletal muscle ischemia provided the first compelling evidence that ischemia-induced microvascular injury is caused, in part, by leukocytes that become adherent to microvascular en dothelium (Engler et aI. , 1987; Jerome et aI. , 1994) . Similar studies supported the concept that leukocytes are also important contributors to reperfusion injury in brain (Dirnagl, 1993; del Zoppo, 1994; Hartl et aI. , 1996) . The strongest evidence is provided by reports documenting reductions in leukocyte adherence and accumulation dur ing postischemic reperfusion concomitant with signifi cant attenuation of ischemic brain injury after adminis tration of monoclonal antibodies to leukocyte or endo-BBB breakdown was similar to that seen during reoxygenation after 9 minutes of asphyxia. Both adherence and loss of BBB integrity resulting from either exogenous PAF or asphyxia reoxygenation could be significantly attenuated by intravenous administration of WEB 2086, a P AF receptor antagonist. Win dow superfusion of superoxide dismutase with PAF attenuated PAF-induced increases in adherence and associated fluorescein leakage, These findings indicate that PAF exhibits proinflam matory effects in piglet brain and that PAF contributes to leu kocyte adherence and BBB breakdown after cerebral ischemia. These PAF effects are mediated by increases in superoxide radical generation. Key Words: Brain-Ischemia-Blood brain barrier-Platelet-activating factor-Superoxide anion Piglets, thelial adhesion molecules (Matsuo et aI. , 1994b) and reductions in ischemic brain injury in adhesion mol ecule-deficient and other relevant gene-targeted mice (Soriano et aI. , 1996) .
It is presumed that leukocytes must first adhere to the endothelium before they can cause injury to endothelial cells; additional injury may occur during firm adherence and extravasation to the extracellular space (Granger and Kubes, 1994) . Leukocyte adherence is a complex process int1uenced by a variety of factors, e. g. , shear stress, oxy gen free radicals, nitric oxide, int1ammatory mediators, and adhesion receptor molecule expression on both leu kocytes and endothelial cells (Granger and Kubes, 1994) . Previous studies of leukocyte-mediated ischemic brain injury assayed brain tissue for levels of myeloperoxidase, an enzyme found exclusively in neutrophils, to quantify leukocyte infiltration (Chopp et aI. , 1994; Matsuo et a\. , 1994a) or histologicaIIy verified the presence of capil lary-occluding and extravasated leukocytes (del Zoppo et aI. , 1991; Caceres et aI. , 1995) . However, these methods do not allow for repeated visualization and quantification of intravascular leukocyte behavior in vivo. We recently reported on our development of an intravital epit1uores cence video microscopy technique that permits mUltiple measures of leukocyte dynamics in the postcapillary ve nules of living animals so that one can elucidate the time course of leukocyte adherence and its functional conse quences in response to proinflammatory stimuli like ce rebral ischemia (Gidday et aI. , 1997) . In piglets, we ob served a progressive increase in leukocytes adherent to cortical venules during the initial 2 hours of reoxygen ation after global cerebral ischemia induced either by asphyxia or aortic cross-clamp; 2 hours after the insult, vascular permeability to sodium fluorescein was signifi cantly elevated. Pretreating asphyxic piglets with a monoclonal antibody against the leukocyte adhesion gly coprotein complex CD lllCD 18 significantly attenuated both the increase in leukocyte adherence and the increase in vascular permeability, indicative of a causal role for adherent leukocytes in endothelial dysfunction during the early reoxygenation period (Gidday et aI. , 1997) . The present study begins to address the precise mechanisms responsible for leukocyte adherence and leukocyte mediated cerebral microvascular injury by examining the participation of platelet-activating factor (PAF) in these events.
Studies in peripheral vascular beds reveal that among inflammatory mediators that influence intravascular leu kocyte-endothelial interactions, PAF exhibits potent ef fects in this regard (Braquet et aI. , 1987) . This lipid au tacoid is released from many cell types, including endo thelial cells, platelets, neutrophils, basophils, neurons, glia, and mast cells. It participates in diverse inflamma tory conditions such as allergic reactions, shock, and ischemia-reperfusion (Braquet et aI. , 1987) . In brain, P AF binding sites have been detailed (Domingo et aI. , 1988) . Platelet-activating factor exhibits potent vasocon strictive effects after topical application to cerebral arte rioles (Armstead et aI. , 1988) . With respect to ischemia, PAF production increases during early postischemic reperfusion (Domingo et aI. , 1994; Nishida and Markey, 1996) , and PAF antagonists have shown efficacy in re ducing brain injury in both adult and neonatal CNS isch emia models (Kochanek et aI. , 1987; Liu et aI. , 1996) . Although these studies indicate a deleterious action of PAF in ischemic brain, studies of P AF' s role in initiating leukocyte adherence and its effects on leukocyte dependent and -independent vascular leakage after cere bral ischemia are still Jacking. In addition, the down stream mediators of P AF-induced leukocyte adherence and leakage have not yet been identified. We undertook the present study to address these questions.
METHODS

Animal preparation
Newborn piglets (less than 5 days old) of either sex were used in this study. Institutional approval was obtained for all protocols. Animals were premedicated with ketamine (20 mg/ kg intramuscularly), mechanically ventilated with a mix of room air and oxygen after a tracheotomy was performed, and anesthetized with 1.0% to 1.5% isoflurane. Both femoral arter-J Cereh Blood Flow Metab, Vol. 19, No. 4, 1999 ies were cannulated for continuous recording of arterial blood pressure and intermittent withdrawal of arterial blood samples for analyses of blood gases, glucose, and hematocrit. End-tidal CO2 and transcutaneous oxygen saturation were continuously monitored by a capnometer and forepaw sensor, respectively. A femoral vein was cannulated for infusion of 5% dextrose in 0.45% normal saline (6 mL'kg-1'h-1) and paralysis (0.25 mg'kg-"h-' pancuronium), Core body temperature was main tained at 3So to 39°C by a thermoregulated heating pad.
A closed cranial window was placed over the right parietal cortex just posterior to the coronal suture after an IS-mm cra niotomy and removal of dura, as described previously (Gidday et aI., 1997) . The window was made completely of Plexiglas, with several circumferentially placed ports for infusion of ar tificial cerebral spinal fluid buffer with or without PAF and other drugs, and for the placement of various instrumentation, including a cannula for intracranial pressure measurement. The top surface of the cranial window was fashioned to create a 2-mm-deep chamber for holding distilled water, into which a water immersion lens was lowered for observation of the pial microcirculation by epifluorescence videomicroscopy.
Epiflnorescence videomicroscopy
We used an epifluorescence microscope with a 100-W mer cury arc light source and a 3.3x photoeyepiece (Gidday et aI., 1997) . Two filter cubes were used: For imaging of rhodamine labeled leukocytes, the excitation filter was 535/35 nm, the dichroic filter was 565 nm, and the emission filter was 610175 nm. A standard fluorescein isothiocyanate cube, with excita tion, dichroic, and emission filters of 470/40 nm, 505 nm, and 510 nm, respectively, was used for imaging of vascular leakage of sodium fluorescein. The coupling of a lO x immersion lens (Olympus, Lake Success, NY, U.S.A.) featuring a 0.4 numeri cal aperture and a 3. I -mm working distance with a Newvicon tube camera (Hamamatsu C2400, Bridgewater, NJ, U.S,A.) with contrast and brightness controls provided real-time, high resolution images of individual fluorescently labeled leuko cytes moving through the pial microcirculation on the surface of the brain. Final image magnification was 290x.
Leukocyte imaging
Circulating leukocytes were labeled in situ by intravenous rhodamine 6G as described earlier (Gidday et aI., 1997) . A loading dose of rhodamine 6G (2 mL/kg of a 0.06 mg/mL solution; Sigma Chemical, St. Louis, MO, U.S.A.) was admin istered 20 minutes before the first baseline imaging session to identify an optimal venular network. Before each imaging ses sion, the rhodamine infusion was reinitiated at a rate of SOO f.LL . min-I. kg-I for 0.5 to 1.0 minute. Immediately thereafter, leukocyte dynamics in the pial microcirculation were video taped for 30 to 45 seconds (Gidday et aI., 1997) . Between imaging sessions, the light path was blocked to avoid potential phototoxic effects.
Protocols
Baseline leukocyte dynamics were imaged at two 30-minute intervals. Within 5 minutes thereafter, animals were either ren dered asphyxic or drug superfusion through the cranial window was initiated. To induce asphyxia, the ventilator was turned off for 9 minutes and the respiratory tubing was clamped. Blood gases were examined during the last minute of asphyxia, after which mechanical ventilation was resumed. In asphyxiated ani mals, we obtained videorecordings of cortical leukocyte dy namics at 60 and 120 minutes of reoxygenation. Videorecord ings were obtained at equivalent times in nonasphyxiated con trol animals or nonasphyxiated control animals superfused with PAF. All window superfusions of drug were initiated at I mL/ min for 1 minute followed by a continuous superfusion at a rate of 50 fLLlmin; displaced cerebral spinal fluid was vented through a port 180 degrees opposite to the inflow cannula. In all animals, vascular permeability was measured after the 120-minute leukocyte imaging time point as detailed below.
Animals were randomly divided into seven groups. Group 1 included nonasphyxic controls (n = 14). Group 2 animals were rendered asphyxic without pretreatment (n = 14). Group 3 animals were rendered asphyxic and treated with a single dose of the PAF receptor antagonist WEB 2086 (10 mg/kg intrave nously) at the onset of reoxygenation (n = 6). Groups 4 and 5 included nonasphyxic animals in which the cranial window was superfused with PAF 10-6 mollL (n = 9) and PAF 10-5 mollL (n = 4), respectively, for 120 minutes. Group 6 included non asphyxic animals pretreated 10 minutes before window super fusion of PAF (10-6 mollL) with WEB 2086 (10 mg/kg intra venously; n = 6); Group 7 animals were nonasphyxic animals in which we simultaneously superfused PAF (10-6 mollL) and the superoxide radical scavenger superoxide dismutase (SOD; 60 U/mL; n = 8) to determine whether superoxide or other downstream radicals were important mediators of PAF-induced leukocyte adherence and fluorescein leakage. After leukocyte imaging at 120 minutes, all animals were given intravenous sodium fluorescein for determination of blood-brain barrier (BBB) integrity.
Quantification of leukocyte-endothelial adherence
Individual leukocytes adherent to the venular endothelium were identified during off-line videotape playback on a high resolution monitor as described previously (Gidday et a!., 1997) . This involved identifying a network of postcapillary venules and determining the three-dimensional endothelial sur face area of this venular network using image analysis software (OPTIMAS, Version 3.0 1, BioScan, Inc., Edmonds, WA, U.S.A.). The number of leukocytes adherent to the venular endothelium within this defined network was determined at each time point by manually counting all leukocytes that re mained stationary for longer than 30 seconds during repeated videotape playback, and converting these values to the corre sponding values for the number of leukocytes per square mil limeter of endothelial surface. The diameters of the venules in which leukocyte adherence was measured in this study ranged from 26 ± 5 to 92 ± 10 fLm.
Vascular permeability
Vascular permeability to low-molecular-weight sodium fluo rescein (MW = 376; 5.5 A radius) was determined in the majority of animals in each group, as described previously (Gidday et a!., 1997) . In brief, at the end of the 120-minute period of observation, 1 mLlkg of a 1.0% solution of sodium fluorescein was administered intravenously for 1 minute. Vid eorecords were obtained just before the injection to obtain ap propriate background values for intravascular and extravascular optical density, during the initial minute of administration at the peak in fluorescence to obtain a maximum optical density value and to identify at least five distinct and pure extravascular locations that were not confounded by small branches or cap illaries, and at 20 minutes after the injection, at which time extravascular optical density values were measured to deter mine the magnitude of solute leak.
Statistical analyses
Differences in leukocyte adherence and vascular permeabil ity within and between groups were determined by Kruskal Wallis one-way analysis of variance with comparison of groups by Dunn's method. All values are reported as means ± SO, and statistical significance was accepted at P values less than 0.05.
RESULTS
Hemodynamic parameters
Mean arterial blood pressure, blood glucose, arterial pH, Paco2, and Pao2 did not differ significantly among the animal groups during baseline conditions or at 60 and 12 0 minutes of postasphyxic reoxygenation. None of these parameters changed significantly with time in the control group. The short-term changes in systemic physi ologic parameters induced by 9 minutes of asphyxia fol lowed by 12 0 minutes of reoxygenation are shown in Table l . During the last minute of asphyxia, animals were severely hypoxic, hypotensive, bradycardic, aci dotic, and hypercapnic. Some asphyxic animals under went cardiac arrest for 1 to 2 minutes during asphyxia, but spontaneously resumed normal sinus rhythms there after. The monitored physiologic variables typically re turned to preasphyxic levels by 30 to 45 minutes of reoxygenation except for arterial pH, which tended to remain slightly acidotic.
Asphyxia-reoxygenation and leukocyteendothelial adherence
The number of adherent leukocytes did not differ among the seven animal groups during baseline condi- 
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Time (min) tions. In group 1 control animals, the number of leuko cytes adherent to postcapillary venules during baseline was 61 ± 25 leukocytes/mm 2 ; during the ensuing 12 0 minutes of observation, a gradual increase in the number of adherent leukocytes was noted, which was significant at 12 0 minutes. In contrast, asphyxia in group 2 animals resulted in a marked increase in the number of adherent leukocytes during 12 0 minutes of reoxygenation relative to controls (Fig. 1) . In addition to increases in the num ber of adherent leukocytes, there were many more rolling leukocytes during reperfusion after asphyxia relative to nonasphyxic controls, but these data were not analyzed quantitatively. In group 3 animals, in which the role of PAF in asphyxia-induced leukocyte adherence was ex amined, administration of the P AF receptor antagonist WEB 2086 immediately on reoxygenation abolished the asphyxia-induced increase in leukocyte adherence to ce rebral venules (Fig. 1) . Representative videoprints of the extent of leukocyte adherence at 2 hours of reoxygen ation after asphyxia relative to that observed at the same time in nonasphyxic controls and asphyxic animals treated with WEB 2086 are shown in Fig. 2 .
PAF and leukocyte-endothelial adherence
The proinflammatory action of PAF was directly ex amined in nonasphyxic animals (groups 4 and 5) by win dow superfusion. Pilot studies revealed no increases in leukocyte adherence to cerebral venules as a result of superfusion with PAF at concentrations of 10-7 mollL and less (data not shown). However, window superfusion with PAF at 10-6 mol/L and 10-5 mollL induced dose dependent increases in leukocyte-endothelial adherence, which increased in a progressive fashion during 12 0 min utes of continuous drug presentation by window super fusion (Fig. 3) . Qualitatively, we noted that PAF also increased in a dose-dependent fashion the number of rolling leukocytes relative to untreated controls. minutes of window superfusion of 10-6 mollL P AF was similar to that measured during 12 0 minutes of reoxy genation after asphyxia. This exogenous PAF-induced leukocyte adherence was completely blocked in animals receiving the PAF receptor antagonist WEB 2086 (Fig.  3, group 6 ).
Asphyxia-reoxygenation, PAF, and vascular permeability
As reported previously (Gidday et al. , 1997) , leakage of sodium fluorescein at 12 0 minutes of reoxygenation after asphyxia was not discretely localized along venules of any particular size, but appeared widespread along all vessels in the venular network. In contrast, no fluores cein leakage was evident in the immediate periarteriolar space. The venular permeability to sodium t1uorescein in the different animal groups is shown in Fig. 4 . In parallel with the observed increases in leukocyte adherence, as phyxia (group 2) or window superfusion with PAF (groups 4 and 5) was associated with significant in creases in vessel permeability to t1uorescein. Treating asphyxic animals with the P AF receptor antagonist WEB 2086 on reoxygenation (group 3) resulted in complete blockade of asphyxia-induced increases in vascular per meability; in fact, t1uorescein permeability in these WEB 2086-treated animals was significantly less than that measured in untreated, nonasphyxic controls (group I). The P AF-induced increase in vascular t1uorescein per meability was also significantly attenuated by WEB 2086 (group 6).
Superoxide radical involvement in P AF -induced leukocyte adherence and vascular permeability
In tests of our hypothesis that oxygen free radicals were important mediators of PAF-induced leukocyte ad herence, we found that cosuperfusion of SOD with 10-6 mollL PAF completely blocked the PAF-induced in crease in leukocyte adherence ( Fig. 3; group 7) . Co superfusion with SOD also attenuated P AF-induced in creases in vascular permeability ( Fig. 4; group 7) . In separate studies, we found that window superfusion with the same concentration of SOD significantly attenuated the elevations in leukocyte adherence and t1uorescein leakage that occur during postasphyxic reoxygenation (unpublished observations).
DISCUSSION
In the present study, window superfusion of P AF in duced marked, dose-dependent increases in both leuko cyte adherence to cerebral pial venules and microvascu lar permeability to sodium t1uorescein. The magnitude of these effects after exposure to 10-6 mol/L P AF was simi lar to that measured during early reoxygenation after (1 mUkg of a 1% so lution for 1 minute). The seven experimental groups include: non asphyxic controls (CON; n = 12); asphyxic animals (AX; n = 12); asphyxic animals treated with WEB 2086 at reoxygenation (AX + WEB; n = 5); animals superfused with 10-6 molll PAF (n = 8); animals superfused with 10-5 mollL PAF (n = 4); animals super fused with 10-6 mol/l PAF 10 minutes after WEB 2086 (n = 6); and animals cosuperfused with 10-6 molll PAF and 60 U/ml SOD (n = 8). (* P < 0.05 versus control group; t P < 0.05 versus asphyxia group; tt P < 0.05 versus PAF 10-6 group.)
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asphyxia. The same dose of the P AF receptor antagonist WEB 2086 that completely blocked PAF-induced in creases in leukocyte-endothelial adherence and BBB breakdown also completely blocked asphyxia-induced increases in leukocyte adherence and fluorescein leak age, indicating that P AF is an important mediator of these proinflammatory events in the cerebral vasculature of the ischemic brain. Because local administration of SOD blocked PAF-and asphyxia-induced increases in leukocyte adherence and fluorescein leakage, we con clude that postischemic leukocyte adherence and loss of endothelial integrity are ultimately mediated by superox ide radical secondary to the production of P AF. Platelet-activating factor is synthesized in brain by acetylation of lyso-PAF or by a de novo pathway involv ing the transfer of phosphocholine to alkylacetyl-sn glycerol (Braquet et aI. , 1987) . Depending on appropriate stimuli, P AF can be produced by, and act on, endothelial cells, neutrophils, platelets, glia, neurons, and mast cells (Braquet et a!. , 1987) . Platelet-activating factor binding sites are present throughout cortical, hippocampal, and striatal gray matter (Domingo et aI. , 1988) . In response to cerebral ischemia, P AF levels increase promptly (Dom ingo et a!. , 1994; Nishida and Markey, 1996) . In gerbil brain subjected to transient (10 minutes) forebrain isch emia, PAF levels measured by radioimmunoassay in creased during ischemia and gradually returned to base line levels by 30 minutes of reperfusion (Domingo et aI. , 1994) , whereas in another report, P AF levels measured by gas chromatography/mass spectrometry increased sig nificantly at 30 minutes of reperfusion and reached maxi mal levels at 1 hour of reperfusion (Nishida and Markey, 1996) . Both studies reflect the rapidity with which P AF synthesis occurs in response to cerebral ischemia.
Rapid, ischemia-triggered P AF production and the acute increase in adherent leukocytes we witnessed in the initial hours of postasphyxic reoxygenation suggest a causal relation between P AF and postischemic leukocy te-endothelial adherence in the cerebral circulation. In deed, P AF is a well-established chemoattractant for leu kocytes in peripheral tissues such as mesentery (Kubes et a!. , 1990b) and hamster cheek pouch (Bjork et aI. , 1983) . In a preliminary report, intra-arterial infusion of P AF induced leukocyte adherence to the rat cerebral venular endothelium during resting conditions (Uhl et aI. , 1993 ). In our model, the presentation of exogenous extracellular PAF by window superfusion resulted in a dose dependent increase in leukocyte adherence that was equivalent to that observed during reoxygenation after asphyxia and that was completely blocked by the P AF receptor antagonist WEB 2086. This antagonist showed similar efficacy against PAF-induced leukocyte adher ence in the mesenteric circulation (Kubes et a!. , 1990a) .
No in vivo studies have directly examined PAP's abil ity to damage the BBB, although intra-arterial infusion of PAF increased BBB permeability in an isolated perfused brain model (Kumar et aI. , 1988) and PAF-induced in creases in microvascular permeability have long been recognized in nonneural organs (Bjork et aI. , 1983; Kubes et a!. , 1990b Kubes et a!. , , 1991 Filep and Foldes-Filep, 1993; Kurose et a!. , 1996) . Our results showing a concentra tion-dependent, WEB 2086-inhibitable increase in fluo rescein leakage after superfusion of P AF through the cranial window are consistent with the aforementioned findings in peripheral vascular beds and provide the first evidence that P AF can alter BBB permeability during nonischemic conditions. The small leakage of sodium fluorescein under baseline conditions in the present study, which may have resulted from mast cell activation or histamine and cytokine release secondary to the sur gical preparation of the cranial window, appears to be partly PAF-dependent, as fluorescein leak in asphyxic animals treated with WEB 2086 was slightly, but signifi cantly, less than that measured in nonasphyxic, untreated control animals.
The concentration of P AF superfused through the cra nial window that was required to elicit an inflammatory response in the cortical microcirculation deserves com ment. Measures of postischemic P AF levels in gerbil brain tissue suggest extracellular levels in the 10-8 to 10-7 mollL range (Nishida and Markey, 1996; Domingo et a!. , 1994) , and in cheek pouch preparations, superfu sion of P AF at concentrations as low as 5 x 10-9 mollL caused leukocyte adherence to venular endothelium and leakage of fluorescently labeled dextran from postcapil lary venules (Bjork et aI. , 1983) . In contrast, in our study and in a study of adult rats (Uhl et a!. , 1993) , cranial window superfusion of P AF at concentrations less than 10-6 mollL had no observable effect on leukocyte endothelial interactions or BBB integrity. The reason that prointlammatory effects are not witnessed at lower PAF concentrations in the cerebral microcirculation relative to peripheral vascular beds may arise from differences in the relative concentration at which the superfused drug reaches its receptors in each preparation; the extent of dilution into the contiguous pool of cerebral spinal fluid for P AF or other solutes infused at low rates through cranial windows will likely be greater than that occurring with the typically high-volume rates of superfusion across spatially well-defined exteriorized tissue prepara tions. Moreover, the relevant receptors effecting PAP's proinflammatory actions likely reside in the intravascular compartment on endothelial cells and leukocytes, and diffusion of extravascularly administered P AF across ce rebral vessels may be more limited than that occurring across peripheral vessels. These uncertainties notwith standing, by our demonstration that intravascular admin istration of a P AF receptor antagonist blocked asphyxia induced and P AF-induced leukocyte-endothelial adher ence and fluorescein leakage, we fulfill an essential criterion required to support the hypothesis that P AF plays a key role in the acute inflammatory response to cerebral ischemia.
Endothelial injury, BBB breakdown, and edema are ob served in numerous models of cerebral ischemia, in cluding piglet asphyxia models (Caceres et aI. , 1995) . Although leukocyte-dependent endothelial disruption and vascular leakage have been clearly documented in noncerebral tissues (Jerome et al. , 1994) , and consider able evidence has accumulated attesting to the neuropro tective effects of leukocyte-directed therapies (del Zoppo, 1994; Hartl et aI. , 1996; Soriano et aI. , 1996) , the possibility that leukocytes participate as mediators of va sogenic edema after stroke has received little experimen tal attention. In the present study, postischemic treatment with the P AF receptor antagonist WEB 2086 reduced both leukocyte adherence and cerebrovascular fluores cein leakage. We cannot rule out the possibility that dis tinct leukocyte and endothelial P AF receptors indepen dently regulate leukocyte adherence and microvascular permeability, respectively, and that the PAF receptor an tagonist blocked both mechanisms simultaneously. How ever, we contend that our results are suggestive of a causal relationship between adherent leukocytes and BBB disruption during postischemic reoxygenation. The dependence of endothelial integrity on adherent leuko cytes was independently verified in an earlier asphyxia study from our laboratory using an adherence-blocking monoclonal antibody to the leukocyte integrin CD18 (G idday et a!. , 1997). Our contention that adherent leu kocytes promote endothelial damage is also consistent with studies demonstrating that neutropenia (Matsuo et aI. , 1994a) or antibodies against leukocyte or endothelial adhesion molecules (Matsuo et aI. , 1994b) reduced edema formation after transient focal ischemia in rats, prevented the rise of intracranial pressure after thrombo embolic stroke in rabbits (Bednar et aI. , 1991) , and abol ished the acute development of vasogenic edema in a rabbit meningitis model (Tuomansen et a!. , 1989) . We only measured microvascular permeability at 12 0 min utes after asphyxia; it is likely that other leukocyte independent mechanisms also contribute to postischemic vasogenic edema at later times.
That SOD blocked leukocyte adherence and BBB per meability after exposure of the brain to P AF suggests that the proinflammatory properties of exogenous P AF are mediated in large part by enhanced generation of superoxide radical. Results obtained from a number of studies suggest that the cellular source for enhanced su peroxide generation after P AF exposure is probably the adherent leukocyte. Leukocytes generate large quantities of superoxide radical by NADPH oxidase as part of their respiratory burst (Shatwell and Segal, 1996) . Incubation of isolated neutrophils with P AF results in increased su peroxide radical production, degranulation, aggregation, and adherence to cultured endothelium (Ingraham et a!. , 1982 ; Kubes et aI. , 1991) . Platelet-activating factor also "primes" neutrophils for oxygen radical generation; ex posure of neutrophils to P AF led to enhanced superoxide generation after contact with interleukin-ll3-stimulated endothelium (Hill et a!. , 1994) . In the mesenteric vascu lar bed, PAF-induced leukocyte adherence to venular en dothelium occurs concurrently with enhanced oxygen radical production (Kurose et aI. , 1996) . Blocking leu kocyte adherence by pretreatment with monoclonal an tibodies against CD lIb/CD 18 on leukocytes or intercel lular adhesion molecule-Ion endothelial cells attenuates PAF-induced oxidative stress (Kurose et aI. , 1996) . In a rat model of focal cerebral ischemia, oxygen free radical production in brain was reduced by neutropenia (Matsuo et aI. , 1995) . Similar conclusions have been advanced in studies of the intestinal microcirculation (Kurose et aI. , 1996) and in experiments with isolated neutrophils (Filep and FOldes-Filep, 1993) . These studies, in conjunction with our results with SOD, strongly suggest that the in crease in barrier permeability we observed after both PAF-and asphyxia-induced elevations in leukocyte ad herence was mediated by superoxide radical released from adherent leukocytes.
Several reports have documented that pretreatment of animals with P AF antagonists results in reduced CNS ischemic injury or improved neurologic recovery from ischemia in different species of mature and immature animals (Kochanek et a!. , 1987; Gilboe et aI. , 1991; Bielenberg et a!. , 1992 ; Liu et a!. , 1996) . The mecha nisms by which P AF antagonists exert such protective effects against ischemia have not been clarified. but the common assumption advanced in these papers was that protection was causally related to a reduced inflamma tory response or a reduction in PAP's potentially delete rious effects on neurons. Platelet-activating factor an tagonists can reduce excitotoxic damage in cultured neu ron preparations as well (Prehn and Krieglstein, 1993) . In contrast, evidence directly linking the well-recognized proinflammatory action of PAF to cerebral ischemic in jury in a mechanistic way is lacking. Our results obtained from asphyxic animals pretreated with WEB 2086, showing a reduction in both leukocyte adherence and BBB disruption, indicate that the protective effects of P AF antagonists in these CNS ischemia models may also result from a blockade of the detrimental effects of neu trophil-endothelial adherence, including microvascular obstruction and loss of BBB integrity.
In conclusion, the present study provides evidence that exogenous extracellular P AF can promote leukocyte ad herence to pial venular endothelium and adherence dependent increases in BBB permeability to small mo lecular weight tracers. We also show that P AF is an important mediator of the acute elevations in leukocyte adherence and the loss of endothelial barrier integrity during early reoxygenation after asphyxia and that su peroxide radical acts downstream from P AF to elicit these effects. Given the accumulating evidence implicat ing oxygen free radical-mediated vascular and parenchy mal injury in stroke, further studies designed to localize and define the mechanisms of PAF-induced free radical formation in ischemic brain are warranted.
